Goldman Sachs resumes coverage on Emerson (NYSE: EMR) with a Neutral rating and $62 price target.

Goldman ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE